4BASEBIO PLC Logo

4BASEBIO PLC

Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.

4BB | IL

Overview

Corporate Details

ISIN(s):
GB00BMCLYF79
LEI:
213800E2DX9EAIUNCB30
Country:
United Kingdom
Address:
25 NORMAN WAY, CB24 5QE CAMBRIDGESHIRE

Description

4BASEBIO PLC is a biotechnology company specializing in the design and manufacturing of synthetic DNA for next-generation therapeutics and vaccines. The company provides high-purity, Good Manufacturing Practice (GMP) grade nucleic acid products, including its proprietary opDNA®, as a plasmid-free alternative to traditional methods. Its technology is engineered to accelerate development timelines, enhance safety, and improve manufacturing scalability for applications in genetic medicine, including mRNA vaccines, viral vector-based gene therapies, and gene editing. 4basebio's solutions aim to eliminate production bottlenecks and de-risk manufacturing for partners in the pharmaceutical and biotechnology sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-02-05 08:00
4basebio Plc - Directors' Dealings
English 35.5 KB
2024-02-02 08:00
4basebio Plc - Long-Term Incentive Plan and Exercise of Options
English 44.9 KB
2023-09-21 08:00
4basebio Plc - Half-year Report
English 324.7 KB
2023-08-01 08:00
4basebio Plc - Grant received from the Bill and Melinda Gates Foundation
English 12.7 KB
2023-06-14 13:52
4basebio Plc - Result of AGM
English 4.3 KB
2023-05-25 08:00
4basebio Plc - Neomatrix Product Supply Agreement
English 11.0 KB
2023-05-11 08:00
4basebio Plc - Final Results and Related Party Transaction
English 71.2 KB
2023-04-03 13:11
4basebio Plc - New lease and expansion of manufacturing capacity
English 6.4 KB
2023-03-31 08:00
4basebio Plc - Holding(s) in Company
English 9.1 KB
2023-02-09 08:00
4basebio Plc - Exercise of Options and Issue of Equity
English 4.8 KB
2023-02-09 08:00
4basebio Plc - Holding(s) in Company
English 9.0 KB
2022-09-30 08:00
4basebio Plc - Half-year Report
English 101.2 KB
2022-09-27 10:05
Second Price Monitoring Extn
English 2.8 KB
2022-09-27 10:00
Price Monitoring Extension
English 2.8 KB
2022-07-13 08:00
4basebio Plc - Director/PDMR Shareholding
English 8.6 KB

Automate Your Workflow. Get a real-time feed of all 4BASEBIO PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 4BASEBIO PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 4BASEBIO PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900
ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.